BioCentury
ARTICLE | Clinical News

HB-101: Phase I started

August 1, 2016 7:00 AM UTC

Hookipa began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate 3 dose levels of intramuscular HB-101 at day 0 and months 1 and 3 in 54 healthy volunteers. ...